You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 154 No. 7, 11 April 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Review Articles
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Sexual Dysfunction With Antihypertensive Drugs

L. Michael Prisant, MD; Albert A. Carr, MD; Peter B. Bottini, PharmD; Diane S. Solursh, PhD; Lionel P. Solursh, MD

Arch Intern Med. 1994;154(7):730-736.


Abstract

The relationship of antihypertensive drugs have a long history of association with sexual dysfunction; however, this relationship is poorly documented. There appears to be a higher rate of sexual dysfunction in untreated hypertensive men compared with normotensive men. Sexual dysfunction increases with age and is associated with physical and emotional symptoms. There are few studies assessing sexual dysfunction with female and African-American hypertensive patients. Sexual dysfunction is associated with impairment of quality of life and noncompliance. Since group data may hide individual drug effects, baseline data should be collected on all patients before initiating therapy with any antihypertensive agent. Although questionnaires may not provide objective information on sexual dysfunction, the response rate to direct questioning may be less than the response rate on a questionnaire and may be affected by the gender or race of the interviewer. Research protocols using a double-blind, placebo-controlled design should assess sexual dysfunction in men and women in a standardized fashion.

(Arch Intern Med. 1994;154:730-736)



Author Affiliations

From the Department of Medicine, Section of Hypertension and Vascular Diseases (Drs Prisant, Carr, and Bottini), and Department of Psychiatry (Drs D. Solursh and L. Solursh), Medical College of Georgia, Augusta.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Factors Affecting the Increased Prevalence of Erectile Dysfunction in Greek Hypertensive Compared With Normotensive Subjects
Doumas et al.
J Androl 2006;27:469-477.
ABSTRACT | FULL TEXT  

Phosphodiesterase 5 Inhibitors for Erectile Dysfunction
Setter et al.
The Annals of Pharmacotherapy 2005;39:1286-1295.
ABSTRACT | FULL TEXT  

Erectile dysfunction
Alexander
British Journal of Diabetes & Vascular Disease 2002;2:244-246.
 

Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial
Black et al.
Hypertension 2001;37:12-18.
ABSTRACT | FULL TEXT  

Long-term Effects on Sexual Function of Five Antihypertensive Drugs and Nutritional Hygienic Treatment in Hypertensive Men and Women: Treatment of Mild Hypertension Study (TOMHS)
Grimm et al.
Hypertension 1997;29:8-14.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.